Antibiotics sometimes exert adverse effects on the pathogenesis of colitis due to the dysbiosis resulting from the disruption of gut homeostasis. However, the precise mechanisms underlying colitogenic effects of antibiotic-induced colitis are largely unknown. Here, we show a novel murine fecal occult bleeding model induced by the combinatorial treatment of ampicillin and vancomycin, which is accompanied by an enlarged cecum, upregulation of pro-inflammatory cytokines IL-6 and IL-12, a reduction in Ki-67-positive epithelial cell number and an increase in the apoptotic cell number in the colon. Moreover, gas chromatography-tandem mass analysis showed that various kinds of metabolites, including glutamic acid and butyric acid, were significantly decreased in the cecal contents. In addition, abundance of butyric acid producer Clostridiales was dramatically reduced in the enlarged cecum. Interestingly, supplementation of monosodium glutamate or its precursor glutamine suppressed colonic IL-6 and IL-12, protected from cell apoptosis and prevented fecal occult blood indicating that the reduced level of glutamic acid is a possible mechanism of antibiotic-induced fecal occult bleeding. Our data showed a novel mechanism of antibiotic-induced fecal occult bleeding providing a new insight into the clinical application of glutamic acid for the treatment of antibiotic-induced colitis.
| INTRODUCTION
Antibiotics sometimes exert adverse effects on the pathogenesis of colitis. Clostridium difficile-associated diarrhea (CDAD) and hemorrhagic colitis are known as antibiotic-induced colitis. Moreover, antibiotic exposure in childhood is a risk factor in inflammatory bowel disease (IBD) and the increasing number of patients being diagnosed with IBD is becoming a social problem in developed countries (Ng et al., 2015) . These adverse effects of antibiotics on the pathogenesis of colitis are highly associated with particular intestinal conditions such as dysbiosis, metabolic disorder and defective epithelial cell growth. For example, mice treated with a combination of four antibiotics including ampicillin (ABPC), vancomycin (VCM), metronidazole (MNZ) and neomycin (Neo) experienced worsened dextran sulfate sodium (DSS)-induced colitis associated with the perturbation of commensal microbiota (Rakoff-Nahoum, Pglino, EslamiVarzaneh, Edberg, & Medzhitov, 2004) . It has been showed that a reduced signal from Toll-like receptors engaged by commensal bacteria exacerbates colitis and the administration of either lipopolysaccharide (LPS) or lipoteichoic acid can revert the disease phenotype (Rakoff-Nahoum et al., 2004) . The gut microbiota also plays an essential role on the regulation of metabolism and the immune system (Furusawa et al., 2013; Matsumoto et al., 2011) . For example, VCM treatment in mice shows a strong effect on the gut microbiota such as Firmicutes as well as on the intestinal metabolism of short-chain fatty acids (SCFAs) such as butyrate (Yap et al., 2008) . Butyrate produced by Clostridia induces differentiation of colonic regulatory T cells which is required for the maintenance of gut homeostasis (Furusawa et al., 2013) . Moreover, antibiotics alter the expression of genes related to the cell cycle leading to the reduction of epithelial activity in colonic epithelium suggesting that commensal microbiota drive colonic epithelial proliferation (Reikvam et al., 2011) . In addition, mice treated with VCM alone exhibited delayed recovery from DSS-induced colitis due to a lack of IL-22 required for wound healing of colonic epithelial cells (Zhao et al., 2016) . Despite the breadth of this research, the precise mechanisms underlying colitogenic effects of antibiotics are still largely unknown.
In the present study, we have showed that a combination of ABPC and VCM is necessary and sufficient to induce fecal occult bleeding in mice. The combinatorial treatment of ABPC and VCM (A + V) induced fecal occult blood, enlarged the cecum, upregulated inflammatory cytokines, reduced the number of Ki-67-positive epithelial cells and induced apoptosis of epithelial cells in the colon. The metabolomic analysis showed reduced levels of SCFAs and glutamic acid (Glu). Importantly, supplementation of monosodium glutamate (MSG) or its precursor glutamine (Gln) improved the antibiotic-induced fecal occult bleeding as well as induced recuperation from fecal occult blood normalized cytokine level and protection from epithelial cell apoptosis. These results suggest that the reduced level of Glu is a possible mechanism of antibiotic-induced fecal occult bleeding. Our studies show a novel mechanism underlying the colitogenic effects of antibiotics and provide a new insight into the clinical application of Glu for the treatment of antibiotic-induced colitis.
| RESULTS

| Combinatorial treatment with ampicillin and vancomycin inhibits tissue regeneration
It has been reported that combinatorial treatment with four antibiotics (ABPC, VCM, MNZ and Neo) aggravated DSSinduced colitis in mice (Rakoff-Nahoum et al., 2004) . First, we gavaged these same antibiotics for three consecutive days and found that all mice tested exhibited occult blood in the feces (n = 5). To determine which of these antibiotics are essential in inducing fecal occult blood, mice were treated with each antibiotic separately. Mice treated with MNZ or Neo as well as untreated control mice tested negative for fecal occult blood. Conversely, 40% (2/5) of mice treated with ABPC or VCM tested positive for fecal occult blood. Interestingly, by combining both antibiotics, ABPC and VCM (A + V) fecal occult bleeding was induced in all mice (8/8) ( Table 1) .
Enlargement of the cecum in A + V-treated mice ( Figure 1a ) was also apparent, and the contents of both the cecum and colon were dark-colored. The weight of the cecum from mice treated with antibiotics was greater than that of control mice. Specifically, the weight of the cecum in mice treated with A + V was approximately three times that of the control mice (Figure 1b) . Fecal occult bleeding, enlarged and dark-colored cecum were also seen in all mice provided A + V in drinking water for 14 days (n = 4).
Although histological assessment of the stomach, jejunum, cecum and colon did not exhibit any inflammatory changes (Supporting Information Figure S1 ), the mRNA expression of IL-6 and IL-12p40 was slightly increased in the colon of mice treated with A + V (Figure 1c ). mRNA expression of IL-1β, IL-10, MIP-1α, IL-17A, IFN-γ, TGF-β and TNF-α, however, remained unchanged (Supporting Information Figure S1B ). In the colonic lamina propria, the proportion of T-cell subsets, neutrophils and macrophages remained unchanged (Supporting Information Figure S1C -F), but MHC-II expression on CD11b-positive macrophages was significantly upregulated in A + V-treated mice ( Figure  1d , Supporting Information Figure S1G ). The induction of pro-inflammatory cytokines in the colon appears to be an indirect effect of the antibiotics, as the antibiotics did not directly induce the cytokines from macrophage cell line RAW264.7 in vitro (data not shown). These results suggest that the association between fecal occult bleeding and immune response is very limited. We subsequently investigated cell proliferation using immunohistochemical analysis. The mean numbers of Ki67-positive cells per crypt were significantly reduced in A + V-treated mice compared to those in control mice, suggesting a decreased proliferative capability in epithelial cells (Figure 1e,f) . This finding was also seen in the mice treated with A + V for 24 hr (Supporting Information Figure S1H ). Moreover, TUNEL staining showed an increased number of apoptotic colonic epithelial cells in A + V-treated mice (Figure 1g ,h). These results suggest that the combinatorial treatment of ABPC and VCM induces fecal occult bleeding due at least in part to defective tissue regeneration.
| Species richness of the gut microbiota was reduced by ABPC and VCM treatment
We investigated the distribution of microbes in the fecal samples at the phylum, class, order, family, genus and species levels using 16S rRNA gene amplicon sequencing. Alpha-diversity was determined by number of operational taxonomic units (OTUs), bias-corrected with Chao1. Chao1 indices showed reduced diversity in mice treated with ABPC, VCM and A + V, which are known as broad-spectrum antibiotics, over the 3-day treatment period (Figure 2a ). The bacterial composition in the cecal contents was analyzed at phylum (Figure 2b ), class (data not shown), order (Figure 2c ), family ( Figure 2d ) and species level (data not shown). A majority of phylum Bacteroidetes were eradicated, while phylum Firmicutes saw a relative increase in VCMtreated and A + V-treated mice (Figure 2b) . A + V treatments also increased Lactobacillales while lowering Clostridiales as compared with these populations in control mice, at the order level (Figure 2c) . At the family level, S24-7, belonging to phylum Bacteroidetes, was dramatically reduced and Lactobacillaceae was increased by these treatments ( Figure  2d ). These results clearly show that the bacterial composition of order Lactobacillales, order Clostridiales and family S24-7 is similarly affected by treatment with ABPC, VCM, or a combination of ABPC and VCM. A similar effect was also seen on the bacterial diversity of mice treated with A + V for 24 hr as seen by the terminal restriction fragment length polymorphism (T-RFLP) method (Supporting Information Figure S2 ).
| A combined administration of ABPC and VCM induces metabolic disorders of carbohydrate, glutamic acid and lipid metabolism
We observed an enlargement of the cecum in antibioticstreated mice, which resembled that seen in germ-free (GF) mice. As the enlarged cecum in GF mice is caused by a metabolic disorder, we analyzed the metabolites in the cecal contents using a gas chromatography-tandem mass spectrometer (GC/MS/MS) with BPX-5 column that allows the measurement of short-chain fatty acids (SCFAs). As shown in Figure  3a and Supporting Information Figure S3 , butyric acid, acetic acid, propionic acid and valeric acid were significantly reduced in ABPC-treated mice and almost completely eliminated in VCM-treated and A + V-treated mice during the three days of treatment. On the contrary, formic acid experienced a significant increase in these mice.
Next, we analyzed other metabolites in the cecal contents using a GC/MS/MS with DB-5 column. Twenty-nine metabolites were significantly changed with antibiotics treatment (Supporting Information Table S1 ). Metabolites which increased in A + V-treated mice were mainly lactic acid and carbohydrates (ribonic acid, arabitol, sorbose and 2-deoxyglucose). Contrarily, aromatic substances (caproic acid, cadaverine, octanoic acid and 5-aminovaleric acid), glutamic acid (Glu) and its metabolites (nicotinic acid, alanine and uracil) were significantly reduced in mice treated with A + V within the 3-day treatment period (Figure 3b , Supporting Information Figure S3B , Table S1 ). These results suggest that antibiotic(s) treatment disturbs the metabolism of Glu, carbohydrates, aromatic substances and SCFAs in the cecum of mice.
| Butyric acid prevents a macrophage cell line from inducting cytokines and induces antimicrobial peptides in a colon carcinoma cell line
To show the pathophysiological relevance of metabolites affected by antibiotics treatment, first we examined the effects of butyrate on monocytes. It has been reported that butyrate decreases the expression of cytokines in peripheral blood mononuclear cells from patients with Crohn's disease (CD) in response to LPS (Segain et al., 2000) . Consistent with previous reports, LPS-induced mRNA expression of MIP-1α, TNFα and IL-1β in macrophage cell line RAW264.7 was significantly suppressed by sodium butyrate (SB) (Figure 4a ).
As butyrate induces the expression of an antimicrobial peptide, cathelicidin, in human colon carcinoma cell line HT29 cells (Steinmann, Agerberth, & Gudmundsson, 2009 ), we further investigated the effect of butyrate treatment on the colon epithelial cells. A mouse colon carcinoma cell line, CMT93, was stimulated with 10 mM SB for 24 h. As shown in Figure 4b , SB induced mRNA expression of secretory leukocyte proteinase inhibitor (SLPI) and lactoferrin, which are known not only as antimicrobial peptides, but also as potent anti-inflammatory agents in the colon (Ho, Charalabos, & Koon, 2013) . However, mRNA expression of SLPI and lactoferrin in A + V-treated mice was unchanged by SB treatment (data not shown). Mouse β-defensin 3 (mBD3), which is the most abundant antimicrobial peptide in the colon, was unchanged ( Figure 4b ).
Oral administration of SB failed to improve fecal occult bleeding in vivo. The expression levels of IL-6 and IL-12p40 remained unchanged (Figure 4c ). Supplementation of butyric acid producer, Clostridium Butyricum, to A + V-treated mice showed a limited effect including the slightly reduced expression of IL-6 and IL-12p40 (Figure 4c ).
| Oral administration of monosodium glutamate and glutamine prevents antibioticinduced fecal occult bleeding
Monosodium glutamate (MSG) or its precursor glutamine (Gln) was administered orally to A + V-treated mice ( Figure  5a ). 37.5% of MSG and 25% of Gln-treated mice tested negative for fecal occult blood (Figure 5b ). Consistent with these results, the cecal contents were no longer dark-colored although the ceca remained enlarged (Figure 5c ).
Gln and MSG reduced the expression of colonic IL-6 and IL-12p40, respectively. (Figure 5d ). We also found that although the reduced number of Ki-67-positive cells in A + V-treated mice remained unchanged (Figure 1e ,f) by treatment with MSG or Gln, apoptotic cells were significantly reduced (Figure 1g,h) .
These results suggest that the retrieval of Glu and Gln in A + V-treated mice in which Glu was reduced in the cecum can improve antibiotic-induced fecal occult bleeding. The reduced level of Glu in the cecum is a possible cause of epithelial cell death leading to fecal occult bleeding.
| DISCUSSION
We have showed that a combination of ABPC and VCM is necessary and sufficient to induce fecal occult bleeding. Some of the VCM-treated mice tested positive for fecal occult blood and altered cytokine expression, metabolism and microbial composition in a similar manner to those of the mice treated with A + V. In the present study, we focused on A + V-treated mice because the disease phenotype was consistently observed within 24 hr of the initial treatment. Moreover, all mice provided A + V ad libitum in drinking water for 14 days also exhibited positive for fecal occult bleeding. These phenotypes could be induced by A + V regardless of administrating pass. We observed increased levels of IL-6, Il-12p40 and MHC-II in A + V-treated mice. However, as the proportions of T-cell subsets, neutrophils and macrophages in the colonic lamina propria were not affected by A + V treatment, the involvement of immune cells is suspected to be very limited to the fecal occult bleeding.
An enlarged cecum was observed in the mice treated with antibiotics (Figure 1a,b) , which resembles that of GF mice (Furusawa et al., 2013) . The enlarged cecum in GF mice is caused by metabolic disorder due to the absence of Clostridiales producing SCFAs. We also observed a significant reduction of SCFAs in A + V-treated mice consistent with that found in a previous report (Yap et al., 2008) . Among the SCFAs, butyric acid is the most important nutrient for the colon epithelium (Kripke, Fox, Berman, Settle, & Rombeau, 1989; Sakata, 1987) and the induction of antimicrobial peptide LL-37 (Canani et al., 2011) . Butyric acid has also been reported to improve DSS-induced colitis in mice (Simeoli et al., 2016) and ulcerative colitis (UC) (Canani et al., 2011) .
In the present study, SCFAs and its producer order Clostridiales experienced a marked decrease with A + V treatment. Furthermore, aromatic substances including caproic acid, cadaverine, valeric acid and octanoic acid were also decreased. These findings suggest that bacterial fermentation of SCFAs is disturbed by antibiotics treatment. In our experiments, butyrate suppressed the induction of pro-inflammatory cytokines IL-1β, MIP-1α and TNFα in a macrophage cell line, and induced antimicrobial peptides, SLPI and lactoferrin, in a colon epithelial cell line. To our knowledge, this is the first report of butyrate inducing SLPI and lactoferrin from colon epithelial cells. However, IL-1β, MIP-1α and TNFα did not experience an increase in A + V-treated mice. Thus, the reduction of butyric acid in A + V-treated mice is not likely to be the cause of the fecal occult bleeding. Indeed, supplementation with sodium butyrate failed to improve A + V-induced fecal occult bleeding (Figure 4c) . Although butyrate producer Clostridium Butyricum was found to slightly suppress the expression of IL-6 and IL-12p40 in the colon (Figure 4c ), the precise mechanism of which remains unclear.
The composition of gut microbiota and the metabolic profile were similar among mice treated with ABPC, VCM or A + V (Figure 3) . Lactic acid and its producer, the order Lactobacillales, were found to be increased in A + V-treated mice (Figure 6, left) . The accumulation of lactate in the large intestine lowers the luminal pH (Bustos et al., 1994) , leading to diarrhea (Saunders & Sillery, 1982) . In fact, it has been reported that the level of lactic acid was higher in patients with UC and antibiotic-induced colitis (Hashizume, Tsukahara, & Yamada, 2003; Vernia et al., 1988) . Moreover, some of the bacteria belonging to order Clostridiales convert lactate into butyrate (Hashizume et al., 2003) .
In our experiments, family S24-7, which is predicted to metabolize carbohydrates, was remarkably reduced in A + V-treated mice. S24-7 is known to inhabit the gut of homeothermic animals, especially herbivores (Ormerod et al., 2016) . It has been reported that an increase in S24-7 occurs during the healing stage of enteritis (Rooks et al., 2014) , and induces T-cell-dependent IgA production (Bunker et al., 2015) . The physiological implication of S24-7 in the fecal occult bleeding remains uncertain, as they are unculturable. Phylum Proteobacteria was increased in A + V-treated mice. This phylum includes Acinetobacter which induces opportunistic infection, as well as Klebsiella, Proteus and Escherichia which are all related to intestinal inflammation, suggesting a colitogenic environment. For example, inoculation of Klebsiella isolated from CD patients could induce Th1 cells in the colon of recipient mice (Atarashi et al., 2017) . In the present study, these colitogenic bacteria were not detected at species level. The abundance of Acinetobacter rhizosphaerae, belonging to phylum Proteobacteria and often shown to exhibit plant growth-promoting traits when isolated from the rhizosphere, was increased by A + V treatment (data not shown) (Gulati, Vyas, Rahi, & Kasana, 2009 ). Warn et al reported that VCM increased the abundance of Acinetobacter rhizosphaerae (Warn et al., 2016) ; however, the pathophysiological relevance is still unclear. Further investigation is needed to show the physiological role of Acinetobacter rhizosphaerae in the maintenance of gut homeostasis.
It is worthy to note here that the levels of Glu metabolites including nicotinic acid and alanine were reduced in the cecal contents by treatment with A + V. Both Glu and Gln are known as the critical energy sources of the gut epithelial cells (Blachier, Boutry, Bos, & Tomé, 2009; Burrin, 2002) . These are provided from luminal and arterial sources. Our data show that the Glu level was remarkably reduced in the cecal contents of A + V-treated mice suggesting that the mucosal Glu metabolism derived from dietary intake was impaired. However, the commensal bacteria which produce Glu in the gut microenvironment are still unidentified (Figure 6 , right). Glu is converted to Gln in the colonic cells, as well as butyrate and acetate in the microflora, which in turn is used by the villi to maintain their integrity (Blachier et al., 2009) . Gln has been shown to exert pluripotent actions, including stimulation of cell proliferation and suppression of apoptosis (Kandil et al., 1995; Papaconstantinou et al., 1998) . In our data, combinatorial treatment with ampicillin and vancomycin reduced the level of Glu and the number of Ki-67-positive epithelial cells and increased the number of apoptotic colonic epithelial cells concomitantly. Interestingly, MSG and Gln treatment provided protection from epithelial cell apoptosis. These results suggest that the combinatorial treatment with ABPC and VCM induces fecal occult bleeding due at least in part to defective tissue regeneration caused by an imbalance between cell proliferation and cell death of intestinal epithelial cells.
It has been reported that Glu prevents nonsteroidal antiinflammatory drug-induced enteritis (Amagase et al., 2012) . Moreover, Gln supplementation attenuates experimental colitis due to the inhibition of inflammatory signaling including NF-κB and STAT, or the inhibition of T-cell migration (Simeoli et al., 2016; Steinmann et al., 2009; Takagi et al., 2006; Vernia et al., 1988) . In our experiments, both Glu and Gln partially suppressed the A + V-induced fecal occult bleeding, although the suppression mechanism remains unknown.
In a clinical setting, Gln level is decreased in the colonic mucosa in patients with active UC (Shiomi et al., 2011) , and the supplementation of Gln improves the disease outcome (Cöeffier, Marion-Letellier, & Déchelotte, 2010) . Glu is the most abundant amino acid in an elemental diet and is traditionally used for treatment of CD in Japan (Takagi et al., 2006) ; however, it is not recommended by European guidelines (Gomollón et al., 2017) because of insufficient evidence and an unknown mechanism. Our data suggest that dysregulation of Glu metabolism induced by antibiotics is highly associated with the development of IBD and provide a new insight into the clinical application of Glu for the treatment of antibiotic-induced colitis. Further investigation is required to show the precise mechanism for how antibiotics disturb Glu metabolism and its associated commensal bacteria in bowel diseases. From these results, the precise mechanisms of fecal occult bleeding induced by antibiotics could not be entirely confirmed and we cannot exclude the possibility of harmful effect of antibiotics on the epithelial cells. For example, A + V treatment may induce defective tissue regeneration leading to the epithelial damage and bleeding, which in turn results in dysbiosis, and ultimately induces colitis at the late phase. Alternatively, we also cannot exclude the involvement of gut microbiota and microbial metabolism because metabolites and microbiota were affected 24 hr following A + V treatment (Supporting Information Figures S2 and  S3) . Importantly, supplementation with MSG did improve the outcome of fecal occult bleeding with protection from apoptosis. These data may at least suggest that the effects of antibiotics on the fecal occult bleeding are associated with defective tissue regeneration.
| EXPERIMENTAL PROCEDURES
| Mice
Six-to eight-week-old male C57BL/6J mice were purchased from CLEA Japan (Tokyo, Japan). Mice were given a routine chow diet (LabDiet 500N, PMI Nutrition International, INC. MI) and autoclaved water under specific pathogen-free conditions. This animal experiment was approved by and carried out according to the guidelines of the Oita University Animal Ethics Committee.
| Antibiotics treatment and examination of occult blood in the feces
Mice were gavaged with 1 mg/body ABPC (Nacalai Tesque, Inc, Kyoto, Japan), 0.5 mg/body VCM (Nacalai Tesque, Inc), 1 mg/body MNZ (Sigma-Aldrich Co. Ltd, St. Louis, MO, USA), 1 mg/body Neo (Nacalai Tesque, Inc) or a combination of 1 mg/body ABPC and 0.5 mg/body VCM using a stomach sonde (Fuchigami, Kyoto, Japan) every 24 hr for three consecutive days. Control mice were given 300µl of distilled water at the same interval. Examination of occult blood in the feces was carried out using Hemoccult (Beckman |
Coulter, Inc, Brea, CA, USA) on day 0 (before administration of antibiotics), day 1 (24 hr after the first administration) and day 3 (24 hr after the last administration). Some mice were given antibiotics with drinking water (ampicillin 1 g/L and vancomycin 0.5 g/L) for 14 days.
| Histological analysis
Mice were euthanized by cervical dislocation 24 hr after the last administration of antibiotics at which time the weight of the cecum with their contents was measured. Tissue samples were fixed with 10% formalin, embedded in paraffin, sectioned at 3 μm and stained with hematoxylin and eosin. For detection of Ki-67, immunohistochemistry was carried out using rat monoclonal anti-mouse Ki-67 antibody diluted 1:50 (Agilent Technologies, CA, USA). Samples were blocked with Protein Block Serum-Free (Agilent Technologies) to reduce nonspecific binding at room temperature for 10 min and then incubated at 4°C overnight with anti-mouse Ki-67 antibody in Antibody Diluent (Agilent Technologies). The sections were incubated at room temperature for 30 min with N-Histofine Simple Stain Mouse MAX-PO (RAT) (Nichirei, Tokyo, Japan). The mean numbers of Ki67-positive cells were calculated by counting positive cells in 10 crypts in each transverse section. For detection of apoptotic cells, TUNEL staining was carried out using TUNEL Apoptosis Detection Kit (GenScript, NJ, USA), according to the manufacturer's instructions. The mean numbers of apoptotic cells were calculated by counting positive cells in three fields (400 × objective) within each section. Samples were observed under a microscope (BX43, Olympus, Tokyo, Japan) mounted with DP27 camera system in a blinded fashion.
| 16S rRNA metagenomic analysis and 16S rRNA terminal restriction fragment length polymorphism (T-RFLP) of cecal microbiota
16S rRNA metagenomic analysis was carried out as described previously (Hisada, Endoh, & Kuriki, 2015) . Isolation of DNA, construction of libraries, deep sequencing and read assembly of the libraries were carried out by Hokkaido System Science (Sapporo, Hokkaido, Japan). Fecal samples from the cecum of four to nine mice were pooled. Fecal DNA was extracted using an automatic nucleic acid extraction system (Magtration System 12GC, Precision System Science, Japan). The 16S rRNA gene amplicon libraries were prepared following the "16S Metagenomic Sequencing Library Preparation Protocol" (Illumina, Inc., San Diego, CA, USA) using the Nextera XT index kit with the following primers (for the V3-V4 region of 16S rDNA of prokaryotes): forward primer 5′-AATGATACGGCG ACCACCGAGATCTACACXXXXXXXXACACTCTT TCCCTACACGACGCTCTTCCGATCTCCTACGGGNB GCASCAG-3′, and reverse primer 5′-CAAGCAGAAGACGG C A T A C G A G A T Z Z Z Z Z Z Z Z G T G A CTGGAGTTCAGACGTGTGCTCTTCCGATCTGACTA CNVGGGTATCTAATCC-3′, the underlined sequences represent the PCR primer region (Pro341F and Pro805R). The libraries were sequenced on the MiSeq platform using MiSeq Reagent Kit v3 with 2 × 301 cycles. The adapter sequences and low-quality regions were trimmed by Cutadapt 1.1 and Trimmomatic 0.32, respectively. Paired-end sequence reads were assembled using the script fastq-join-1.1.2-537. Further data processing was carried out using the open-source software pipeline "Quantitative Insights into Microbial Ecology" (QIIME) version 1.8.0. Reads were trimmed of primers, and sequence quality control was carried out using QIIME's script (sequences length 200-1,000 nucleotides; minimum average quality score 25; maximum length of homopolymer runs 6).
Operational taxonomic units (OTUs) were formed at 97% similarity using UCLUST (de novo OTU picking). The phylogenetic assignment of representative sequences from each OTU was carried out with a 16S reference dataset obtained from Greengenes version 13_8, and chimeric sequences were removed using ChimeraSlayer. Summary of taxonomic assignments was plotted, and alpha diversities were calculated by QIIME. 16S rRNA T-RFLP was carried out by TechnoSuruga Laboratory Co, Ltd. (Shizuoka, Japan) as described previously (Nagashima, Hisada, Sato, & Mochizuki, 2003) . Fecal DNA was amplified by PCR using forward primer 516f (5′-TGCCAGCAGCCGCGGTA-3′) and reverse primer 1510r (5′-GGTTACCTTGTTACGACTT-3′), digested with BslI and analyzed by ABI PRISM 3,130 x1 Genetic Analyzer System (Thermo Fisher Scientific, Waltham, MA, USA). The phylogenetic assignment of OTU was carried out according to reference Human Fecal Microbiota T-RFLP Profiling (https://www.tecsrg.co.jp/t-rflp/t_rflp_hito_OTU.html).
| Gas chromatography-tandem mass spectrometer analysis for metabolites in the cecal contents
Metabolites in the cecal contents were determined by a gas chromatography-tandem mass spectrometer (GC/MS/MS), GC/MS-TQ8040 (Shimazu, Kyoto, Japan). A BPX-5 column (30 m × 0.25 mm i.d; film thickness 1.00 µm, Trajan Scientific and Medical, Vic., Australia) was used for SCFAs, and a DB-5 column (30 m × 0.25 mm i.d; film thickness 1.00 µm, J&W Scientific Inc, Folsom, CA, USA) was used for other metabolites.
Short-chain fatty acids in the cecal contents were extracted with methanol. 180 µl of supernatant was mixed with 20 μl of 100 mM n-octylamine-DMT-MM and then applied on a GC/ MS/MS. For other metabolites, cecal samples extracted with methanol were added to 1.0 mg/ml isopropylmalic acid as an internal standard with distilled water and chloroform. 20 μl of supernatant was dried up and then mixed with 120 μl of 20 mg/ml methoxyamine hydrochloride in pyridine to oximate. Derivatization was carried out using 60 µl of N-methyl-Ntrimethylsilyltrifluoroacetamide and then applied on a GC/ MS/MS. The analysis conditions are shown in Table 2 . Peaks were detected using the GCMSsolution software (Shimazu), and the alkane series mixture (C9 to C33) was used to standardize retention time. Metabolites were detected by the Smart Metabolites Database (Shimazu) which registered 12 spectrums for BPX-5 column and 475 spectrums for DB-5 column.
4.6 | Glutamate, glutamine, sodium butyrate and Clostridium Butyricum treatment for the antibiotic-induced fecal occult bleeding Monosodium L-glutamate monohydrate (MSG: Wako Pure Chemical Industries, Ltd, Kyoto, Japan), L-glutamine (Gln: Sigma-Aldrich Co. Ltd), sodium butyrate (SB; Wako Pure Chemical Industries, Ltd) or probiotics including Clostridium Butyricum (CB, Miyarisan, Tokyo, Japan) were orally administered to the antibiotic-induced fecal occult bleeding in mice. A + V-treated mice were given 3 g/dl of MSG or 3 g/ dl Gln or 2 g/dl SB three days before the antibiotics treatment. 6 mg of CB was orally administered by stomach sonde together with antibiotics for three days.
| Cell lines, cell culture and treatments
Mouse monocyte cell line RAW267.4 (ATCC, Manassas, VA, USA) and mouse colon carcinoma cell line CMT93 (ECACC, Salisbury, UK) were grown in Dulbecco's modified Eagle's medium (DMEM; Thermo Fisher Scientific) with 10% FCS, at 37°C in 5% CO 2 . RAW 267.4 cells were stimulated with LPS (3 ng/ml) for 24 hr in the presence or absence of 10 mM sodium butyrate or antibiotics. CMT93 cells were treated with 10 mM SB for 24 hr. Cells were then harvested for the measurement of cytokines by real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis.
| RNA extraction and real-time qRT-PCR
Tissue samples from the colon or cell lines were homogenized in TRI Reagent (Cosmo BIO Co. Ltd, Tokyo, Japan), and then total RNA was extracted according to the manufacturer's instructions. cDNA synthesis was carried out using a Verso cDNA Synthesis Kit (Thermo Fisher Scientific Inc). qRT-PCR was carried out using a KAPA SYBR FAST qPCR Kit (Kapa Biosystems, Wilmington, MA, USA) with a fluorescence temperature cycler (LightCycler 96, Roche Diagnostics, Indianapolis, IN, USA). The sequences of primers are listed as follows: β-actin F: CTTCCTCCCTGGAGAAGAGCTATGAGC, R: GCCTAGAAGCACTTGCGGTGCACG; IL-1β F: GAG TGTGGATCCCAAGCAAT, R: TACCAGTTGGGGAAC TCTGC; IL-6 F: CCGGAGAGGAGACTTCACAG, R: CA GAATTGCCATTGCACAAC; IL-10 F: GGTTGCCA AGCCTTATCGGA, R: AAATCGATGACAGCGCCTC; IL-12p40 F: CCTGAAGTGTGAAGCACCAA, R: TCA GGGGAACTGCTACTGCT; IL-17A F: GGCCCTCAG ACTACCTCAACC, R: TGAGCTTCCCAGATCACAGAG; TGFβ F: CATCCATGACATGAACCGGC, R: CTTCT CTGTGGAGCTGAAGCA; IFNγ F: ATGAACGCTA CACACTGCATC, R: CCATCCTTTTGCCAGTTCCTC; TNF-α F: CCACCACGCTCTTCTGTCTA, R: TCCTCCAC TTGGTGGTTTGT; MIP-1α F: TGCCCTTGCTGTTCTTC TCT, R: GATGAATTGGCGTGGAATCT; secretory leukocyte inhibitor (SLPI) F: GGCCTTTTACCTTTCACGGTG, R: TACGGCATTGTGGCTTCTCAA; mouse β difensin3 (mBD3) F: CTTTGCATTTCTCCTGGTGC, R: GCC TCCTTTCCTCAAACT; lactoferrin F: TCAAGAAAT CCTCCACCCGC, R: ACACGAGCTACACAGGTTGG. Amplification conditions were as follows: 45 cycles of 95°C (10 s), 60°C (20 s) and 72 C (1 s). All data were analyzed by LightCycler software (Roche Diagnostics, Basel, Switzerland) and normalized to the β-actin expression. The fold difference relative to the β-actin was shown.
| Isolation of intestinal lymphocytes and myeloid cells
Colons were opened longitudinally, placed in HBSS with 5 mM EDTA and incubated at 37°C for 15 min in a shaking water bath. After washing in PBS, muscle layers were removed with tweezers. The tissues were then cut into small pieces and incubated with RPMI1640 containing 4% FBS, 1 mg/ml collagenase type II, 0.5 mg/ml dispase and 25 μg/ ml DNase I for 35 min at 37 °C in a shaking water bath. The digested tissues were filtered through a 40-μm cell strainer.
| Flow cytometry analysis
The following antibodies were used: anti-CD3: PE (Thermo Fisher Scientific), anti-CD4: FITC, anti-CD8: PerCP Cy5.5, anti-Foxp3: APC, anti-CD11b: anti-F4/80, anti-MHC classII: Alexa Fluor 700 (BioLegend, CA, USA) and zombie red (BioLegend) after blockade of Fc receptors. The intracellular expression of Foxp3 in CD4 + T cells was analyzed using a Foxp3/Transcription Factor Staining Buffer Set (Thermo Fisher Scientific) according to the manufacturer's instructions. Data were acquired using a FACSVerse or a LSRFortessa (BD Biosciences, NJ, USA) and analyzed using FlowJo software (BD Biosciences).
| Statistical analysis
Data are expressed as mean ± standard deviation (SD). Differences between two groups were analyzed by Student's t test. ANOVA with Tukey's test was used to compare three or more groups using GraphPad Prism 6.0 (GraphPad Software Inc., San Diego, CA, USA). p values <0.05 were considered to be significant.
